Peter H H, Knoop F, Kalden J R
Z Immunitatsforsch Exp Klin Immunol. 1976 Apr;151(3):263-81.
Spontaneous cell-mediated cytotoxicity (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) against 51Cr labeled allogeneic target cells of a human melanoma cell line (IGR3) were determined with purified effector lymphocytes and defibrinated whole blood from 14 melanoma patients and 13 healthy control persons. Peripheral blood lymphocytes were isolated by Ficoll gradient centrifugation (fraction F); subsequently the phagocytic and adherent cells were removed and the supernating cell population (fraction fff) was passaged through IgG anti-IgG columns to obtain a B cell free lymphocyte suspension (fraction fff-c). cells from the 3 lymphocyte fractions and from defibrinated whole blood were simultaneously tested for cytotoxic activity against unsensitized IGR3 target cells (SCMC assay) and IGR3 cells perviously sensitized with a rabbit anti-melanoma IgG (ADCC assay). Dose-response curves were established with all lymphocyte fractions and with whole blood. The following results were obtained. 1. With all lymphocyte fractions tested, ADCC was approximately 15 time higher than SCMC, whereas with whole blood, the difference tended to be less pronounced. 2. Elimination of phagoctic and adherent cells had no significant effect on SCMC and ADCC. 3. Passage over IgG anti-IgG columns drastically reduced cytotoxicity in both assays without, however, completely abolishing it. 4. The only difference seen between lymphocyte cytotoxicity of melanoma patients and control persons was a slight, but non-significant depression of SCMC and ADCC in melanoma patients. The results confirm and extend our previous report that SCMC against an allogeneic tumor cell-line is due to not-specific "Null" or "K" cell-activity rather than to specific T cell cytotoxicity. In one experiment freshly explanted melanoma cells were labeled with 51Cr and reacted wiht autologous blood and purified lymphocyte fractions. It was found that cellular cytotoxicity depending on serum factors (ADCC) was an effective lytic mechanism, whereas T cell-mediated cytotoxicity could not be demonstrated.
采用14例黑色素瘤患者和13名健康对照者的纯化效应淋巴细胞和去纤维蛋白全血,测定了针对人黑色素瘤细胞系(IGR3)的51Cr标记同种异体靶细胞的自发细胞介导细胞毒性(SCMC)和抗体依赖性细胞毒性(ADCC)。通过Ficoll梯度离心分离外周血淋巴细胞(F组分);随后去除吞噬细胞和贴壁细胞,将上清细胞群体(fff组分)通过IgG抗IgG柱,以获得无B细胞的淋巴细胞悬液(fff-c组分)。同时检测3个淋巴细胞组分和去纤维蛋白全血对未致敏IGR3靶细胞的细胞毒性活性(SCMC试验)以及先前用兔抗黑色素瘤IgG致敏的IGR3细胞的细胞毒性活性(ADCC试验)。用所有淋巴细胞组分和全血建立剂量反应曲线。得到以下结果。1. 在所有测试的淋巴细胞组分中,ADCC比SCMC高约15倍,而在全血中,差异往往不太明显。2. 去除吞噬细胞和贴壁细胞对SCMC和ADCC没有显著影响。3. 通过IgG抗IgG柱处理在两种试验中均显著降低了细胞毒性,但并未完全消除。4. 黑色素瘤患者和对照者的淋巴细胞细胞毒性之间唯一的差异是黑色素瘤患者的SCMC和ADCC略有降低,但不显著。这些结果证实并扩展了我们之前的报告,即针对同种异体肿瘤细胞系的SCMC是由于非特异性的“Null”或“K”细胞活性,而非特异性T细胞细胞毒性。在一项实验中,将新鲜分离的黑色素瘤细胞用51Cr标记,并与自体血液和纯化的淋巴细胞组分反应。发现依赖血清因子的细胞毒性(ADCC)是一种有效的溶解机制,而未证实T细胞介导的细胞毒性。